These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6702442)

  • 21. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
    Tuschy U; Szeszat S; Meinhold J
    Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of renal concentrating ability.
    Delin K; Aurell M; Bendz H
    Br Med J; 1979 Mar; 1(6167):888-9. PubMed ID: 435850
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of the Schwartz-Bartter syndrome after the administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin.
    Valkusz Z; Laczi F; László FA
    Endokrinologie; 1982 Jul; 79(3):345-8. PubMed ID: 7128548
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case report. Desmopressin caused water intoxication].
    Norée E; Belfrage E; Zachrisson I; Enochsson E
    Lakartidningen; 1994 Feb; 91(6):515-6. PubMed ID: 8114585
    [No Abstract]   [Full Text] [Related]  

  • 26. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
    Radó J; Pató E
    Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coagulo-fibrinolytic response to intranasal administration of low dose desmopressin acetate (DDAVP) in normal and hemophiliac subjects].
    Kakishita E; Uomoto M; Nishida K; Hara M; Nagai K
    Rinsho Byori; 1982 Nov; 30(11):1230-4. PubMed ID: 7182595
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of renal concentrating ability.
    Curtis JR; Donovan BA
    Br Med J; 1979 Feb; 1(6159):304-5. PubMed ID: 421089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary concentration capacity in neonatal hydronephrosis].
    Orejas Rodríguez-Arango G; García Vicente S; Rey Galán C; Ramos Aparicio A; Santos Rodríguez F; Málaga Guerrero S
    An Esp Pediatr; 1993 Jan; 38(1):10-2. PubMed ID: 8439070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Water intoxication with desmopressin in children: report of three cases].
    de la Gastine B; de la Gastine G; Mosquet B; Letouzé N; Jokic M; Coquerel A
    Therapie; 2007; 62(1):65-7. PubMed ID: 17474187
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
    Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmopressin: more cases of water intoxication.
    Prescrire Int; 2010 Dec; 19(111):283. PubMed ID: 21360853
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute water intoxication after intranasal desmopressin in a patient with primary polydispsia.
    Ferrer J; Halperin I; Conget JI; Cabrer J; Esmatjes E; Vilardell E
    J Endocrinol Invest; 1990 Sep; 13(8):663-6. PubMed ID: 2273207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal administration of desmopressin acetate (DDAVP) to hemophiliacs.
    Dewald DL; Briggs B; Smith RE
    Thromb Res; 1980 Jun; 18(5):617-22. PubMed ID: 6774441
    [No Abstract]   [Full Text] [Related]  

  • 36. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
    László FA; Czakó L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal concentrating capacity test by desmopressin in children: intranasal or intravenous route?
    Feber J; Cochat P; Hadj-Aïssa A; Dubourg L; Wright C; Pozet N
    Am J Nephrol; 1993; 13(2):129-31. PubMed ID: 8342578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Possibilities in the determination of kidney concentrating ability as based on the DDAVP [deamino-(8-D-arginine)-vasopressin] test].
    Nádvorníková H; Schück O; Cort JH
    Vnitr Lek; 1978 Oct; 24(10):1026-31. PubMed ID: 706183
    [No Abstract]   [Full Text] [Related]  

  • 39. [The treatment of diabetes insipidus in 1999].
    Ajzenberg C; Warnet A
    Rev Med Interne; 1999 Aug; 20 Suppl 3():399s-400s. PubMed ID: 10480192
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.